top of page
Newspapers

NEWS.

Search

This follow-up to the 2019 report by the Lancet Commission outlines roadblocks that have undermined progress towards ending TB over the past five years and provides recommendations, lessons that can be learned from the global response to COVID-19, and how a new set of diagnostics, therapeutic, and preventive tools - including new vaccines - already available or in the pipeline promises the possibility of transformative progress.


The 2019 Lancet Commission on Tuberculosis laid out an optimistic vision for how to build a tuberculosis-free world through smart investments based on sound science and shared responsibility. Since then, several major strides have been made towards ending tuberculosis, including substantive improvements in treatment outcomes for people with drug-resistant disease. Although COVID-19 has undermined global progress, many African countries have sustained declines in tuberculosis mortality rates. With excellent short-course preventive regimens and several late-stage vaccine candidates, tuberculosis prevention is also on the cusp of a revolution. Still, much more can be done to fully implement the Commission's recommendations and realise the ambitious targets set out at the UN High-Level Meeting (HLM) on tuberculosis in 2018. In the 5 years since the HLM, more than 7 million people have died of tuberculosis; their deaths are a profound tragedy and a reminder of the urgency of accelerating momentum.


Click here to read the report.

4 views0 comments


Safe, effective, and accessible vaccines are urgently needed to end tuberculosis (TB) by 2030. The 6th Global Forum on TB Vaccines, convened virtually 22–25 February 2022, was hosted by Toulouse, France, under the high patronage of President Emmanuel Macron, and the patronages of Minister for Solidarity and Health, Olivier Véran, and Minister for Higher Education, Research and Innovation, Frédérique Vidal. The theme for the meeting, “New horizons for TB vaccines”, reflected the changing landscape in which TB vaccine research and development (R&D) is being conducted: TB vaccines advancing into late-stage clinical trials and toward licensure, innovative research toward diversifying the TB vaccine pipeline and developing the next generation of candidates, increasing political, civil society, and community support for TB vaccines, and the ongoing COVID-19 pandemic. In this report, we summarize key themes and findings from the meeting, highlighting progress and gaps in the TB vaccine field.


Read the report to learn more about:

  • The TB R&D landscape under the theme “New horizons for TB vaccines”

  • Key themes, progress, and gaps in the TB vaccine field

  • Sessions on cutting-edge preclinical and clinical vaccine research

  • New TB vaccine preparedness and advocacy priorities

Click here for the full report

4 views0 comments

The 6th Global Forum on TB Vaccines will take place from February 22-24, 2022 in Toulouse, France, under the high patronage of Mr. Emmanuel Macron, President of the French Republic, and under the patronage of Mr. Olivier Véran, Minister for Solidarity and Health. The theme of the 6th Global Forum is New horizons for TB vaccines. The 6th Global Forum on TB Vaccines is currently planned to be a hybrid conference, with options for in-person and online participation. The Organizing Partners are carefully monitoring the COVID-19 pandemic and its potential impact on the in-person component of the 6th Global Forum. Information will be posted as it becomes available. Read our full COVID statement.


Abstracts and Registration


The Global Forum Organizers and Organizing Committee invite abstracts for potential oral or poster (on-site or virtual) presentation at the 6th Global Forum on TB Vaccines. The abstract submission platform will be open from Sep. 1-Oct. 15, 2021. Learn more. Registration for the 6th Global Forum will open in October 2021.


Virtual Global Forum Sessions Online


Did you miss a session from the Virtual Global Forum? Is there a session you would like to watch again? Recordings of sessions from the Virtual Global Forum are available on-demand for registered participants until Oct. 22, 2021. Recordings of the following sessions are now available online for public viewing:

Presentations from the Virtual Global Forum on TB Vaccines are available on the program page of the Virtual Global Forum website.


Sponsorship Opportunities


Sponsorship opportunities are available to support the 6th Global Forum and to raise your organization's visibility throughout the meeting.

Contact us to discuss sponsorship opportunities in more detail.


About the Forum


The Global Forum on TB Vaccines is the world’s largest gathering of stakeholders striving to develop new vaccines to prevent TB. It provides an important and unique opportunity to review the state of the field, share the latest research findings, and identify new and innovative approaches to TB vaccine R&D, with the end goal of developing and deploying new TB vaccines as quickly as possible.

Follow the Global Forum on New TB Vaccines on Twitter for news and updates.




85 views0 comments
1
2
bottom of page